Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS;Individuelle aspekte der lebensqualität von patienten mit chronischen schmerzen: Anwendungsbeobachtung zur therapie mit fentanyl-TTS

MMW-Fortschritte der Medizin

Volumn 147, Issue 14 SUPPL., 2005, Pages 33-40

  Zimmermann, Michael ^a   Waap, I ^b  

^a GOETHE UNIVERSITY   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

Author keywords

Chronic pain; Mobility; Opioid therapy; Quality of life

Indexed keywords

DICLOFENAC; DIPYRONE; FENTANYL; FENTANYL TTS; IBUPROFEN; MORPHINE; OPIATE; TILIDINE; TRAMADOL;

ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; SEXUALITY; SIDE EFFECT; VISUAL ANALOG SCALE; WALKING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHILD; CHRONIC DISEASE; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICK ROLE;

EID: 17444391270     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Allan, L, et al.: Randomised crossover trial of transdermal fentanyl and sustained-release oral morphine for treating non-cancer pain. Br. Med. J. 322 (2001), website, p17.
2. Ambler, N., et al.: Sexual difficulties of chronic pain patients. Clin. J. Pain 17 (2001), 138-145.
3. Berliner, M., et al.: Fentanyl-TTS bei durch rheumatoide Arthritis bedingten Schmerzen. Akt. Rheumatol. 27 (2002), 230-235.
4. Bullinger, M.: Lebensqualität: Ein neues Thema in der Medizin? Zentralbl. Gynakol. 124 (2002), 153-156.
5. Bowling, A., et al.: Measuring disease: a review of disease-specific quality of life measurement scales. Buckingham: Open University Press 1995:5.
6. Dellemijn, P., et al.: Treatment with transdermal fentanyl in neuropathic pain. J. Pain. Symptom. Manage. 16 (1998), 220-229.
7. Donner, B., et al.: Long-term treatment of cancer pain with transdermal fentanyl. J. Pain Symptom. Manage. 15 (1998), 168-175.
8. Grond, S., et al.: Transdermal fentanyl in the long-term treatment of cancer pain. Pain 69 (1997), 191-198.
9. Kohlmann, T.: Bevölkerungsbezogene Epidemiologie am Beispiel chronischer Rückenschmerzen. In: Zenz, M., et al.: Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 2001, 221-229.
10. McGee, H. M.: Assessing the quality of life of the individual: the SEIQoL with healthy and a gastroenterology unit population. Psychol. Med. 21 (1991), 749-759.
11. Monga, T., et al.: Sexuality and sexual adjustment of patients with chronic pain. Disabil. Rehabil. 20 (1998), 317-329.
12. Rajagopal, A., et al.: Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J. Pain Symptom. Manage. 26 (2003), 1055-1061.
13. Ringe, J. D., et al. Rückenschmerz bei Osteoporose: Verbesserte Möglichkeit für Bewegungstherapie unter einer Behandlung mit Fentanyl-TTS. Z. Rheumatol. 60 (2001), (Suppl. 1), P13-08.
14. Sabatowski, R., et al.: Driving ability under longterm treatment with transdermal fentanyl. J. Pain Symptom. Manage. 25 (2003), 38-47.
15. Simpson, R. K., et al.: Transdermal fentanyl as treatment for chronic low back pain. J. Pain Symptom. Manage. 14 (1997), 218-224.
16. Theodoridis, T., et al.: Fentanyl-TTS bei arthrosebedingten Schmerzen. Z. Orthop. 140 (2002), 217-222.